Skip to main content

Detection of the Content and Activity of the Transcription Factor AP-1 in a Multistage Skin Carcinogenesis Model

  • Protocol
Cancer Cell Signaling

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 218))

  • 930 Accesses

Abstract

Investigation of transcription factor activity in animal tissue during the early stage of cancer development can be difficult because of a low number of affected cells in a background of a large number of normal cells. We have used a well-established multistage skin carcinogenesis model to study the effect of manganese superoxide dismutase on the activity of AP-1 during an early stage of mouse skin carcinogenesis. The DNA binding activity of AP-1 proteins to a concensus DNA regulatory binding element known as TRE (TPA Responsive Element) is used as an in vitro assay for AP-1 activity in the nucleus of skin cells. This activity is detected by electrophoretic mobility shift assay (EMSA) which is based on the ability of specific proteins to bind and retard the migration of radioactive labeled oligonucleotides on a native gel. The presence of a specific protein in the complex can be identified by adding to EMSA an antibody specific for that protein, which will result in supershift complexes on the gel. The presence of the proteins in question can be further verified by standard Western analysis of the nuclear proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weisiger, R. A. and Fridovich, I. (1973) Superoxide dismutase: Organelle specificity. J. Biol. Chem. 248, 4793–4796.

    PubMed  CAS  Google Scholar 

  2. Halliwell, B., Zhao, K., and Whiteman, M. (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res. 31(6), 651–669.

    Article  PubMed  CAS  Google Scholar 

  3. McCord, J. M. and Fridovich, I. (1988) Superoxide dismutase: the first twenty years (1968–1988). Free Radic. Biol. Med. 5(5–6), 363–369.

    Article  PubMed  CAS  Google Scholar 

  4. Oberley, L. W. and Buettner, G. R. (1979) Role of superoxide dismutase in cancer: a review. Cancer Res. 39, 1141–1149.

    PubMed  CAS  Google Scholar 

  5. Sun, Y. (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 8, 583–599.

    Article  PubMed  CAS  Google Scholar 

  6. St. Clair, D. K. (1996) Tumor suppression by manganese superoxide dismutase: A novel function of MnSOD? A commentary. Oncol. Rep. 3, 429–432.

    CAS  Google Scholar 

  7. Kiningham, K. K. and St. Clair, D. K. (1997) Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res. 57, 5265–5271.

    PubMed  CAS  Google Scholar 

  8. Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., and Agrawal, B. B. (1998) Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor κB and activated protein-1. J. Biol. Chem. 273, 13,245–13,254.

    Article  PubMed  CAS  Google Scholar 

  9. Zhao, Y., Kiningham, K. K., Lin, S.-M., and St. Clair, D. K. (2001) Overexpression of MnSOD prevents murine fibrosarcoma (FsaII) cells from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: Involvement of MARK and NF-kB pathways. Antioxidants Redox Signal. 3, 375–385.

    Article  CAS  Google Scholar 

  10. Zhao, Y., Xue, Y., Oberley, T. D., Kiningham, K. K., Lin, S.-M., Yen, H. C., et al. (2001) Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 61, 6082–6088.

    PubMed  CAS  Google Scholar 

  11. Fischer, S. M., Jasheway, D. W., Klann, R. C., Butler, A. P., Patrick, K. E., Baldwin, J. K., and Cameron, G. S. (1989) Correlation of phobol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. Cancer Res. 49, 6693–6699.

    PubMed  CAS  Google Scholar 

  12. Iversen, O. H. (1995) Of mice and men: a critical reappraisal of the two-stage theory of carcinogenesis. Crit. Rev. Oncology 6, 357–405.

    CAS  Google Scholar 

  13. Troll, W. (1991) Prevention of cancer by agents that suppress oxygen radical formation. Free Radic. Res. Commun. 12–13, 751–757.

    Article  PubMed  Google Scholar 

  14. Slaga, T. J. (1995) Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 369, 1671–1674.

    Google Scholar 

  15. Kouzarides, T. and Ziff, E. (1988) The role of the leucine zipper in the Fos-Jun interaction. Nature 336, 646–651.

    Article  PubMed  CAS  Google Scholar 

  16. Gopalakrishna, R. and Anderson, W. B. (1989) Ca2+-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA 86, 6758–6762.

    Article  PubMed  CAS  Google Scholar 

  17. Nishizuka, Y. (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661–665.

    Article  PubMed  CAS  Google Scholar 

  18. Palumbo, E. J., Sweatt, J. D., Chen, S.-J., and Klann, E. (1992) Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem. Biophys. Res. Comm. 187, 1439–1445.

    Article  PubMed  CAS  Google Scholar 

  19. McSwine-Kennick, R. L., McKeegan, E. M., Johnson, M. D., and Morin, M. J. (1991) Phorbol diester-induced alterations in the expression of protein kinase C isozymes and their mRNAs. J. Biol. Chem. 266, 15,135–15,143.

    PubMed  CAS  Google Scholar 

  20. Verma, A. K., Pong, R. C., and Erickson, D. (1986) Involvement of protein kinaseC activation in ornitine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphor-bol-13 acetate. Cancer Res. 46, 6149–6155.

    PubMed  CAS  Google Scholar 

  21. Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16,483–16,486.

    PubMed  CAS  Google Scholar 

  22. Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., and St. Clair, D. K. (1996) The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98, 1253–1260.

    Article  PubMed  CAS  Google Scholar 

  23. Ibrahim, H., Lee, U.-S., Yen, H. C., St. Clair, D. K., and Chow, C. K. (2000) Antioxidant and oxidative status in tissues of managanese superoxide dismutase transgenic mice. Free Radic. Biol. Med. 28, 379–402.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Zhao, Y., St. Clair, D.K. (2003). Detection of the Content and Activity of the Transcription Factor AP-1 in a Multistage Skin Carcinogenesis Model. In: Terrian, D.M. (eds) Cancer Cell Signaling. Methods in Molecular Biology™, vol 218. Humana Press. https://doi.org/10.1385/1-59259-356-9:177

Download citation

  • DOI: https://doi.org/10.1385/1-59259-356-9:177

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-075-5

  • Online ISBN: 978-1-59259-356-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics